These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 32419227)
1. Relative rate of change in cognitive score network dynamics via Bayesian hierarchical models reveal spatial patterns of neurodegeneration. Cespedes MI; McGree JM; Drovandi CC; Mengersen K; Fripp J; Doecke JD Stat Med; 2020 Sep; 39(21):2695-2713. PubMed ID: 32419227 [TBL] [Abstract][Full Text] [Related]
2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition. Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799 [TBL] [Abstract][Full Text] [Related]
3. Comparisons of neurodegeneration over time between healthy ageing and Alzheimer's disease cohorts via Bayesian inference. Cespedes MI; Fripp J; McGree JM; Drovandi CC; Mengersen K; Doecke JD BMJ Open; 2017 Feb; 7(2):e012174. PubMed ID: 28174220 [TBL] [Abstract][Full Text] [Related]
4. Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer's dementia. Choi M; Youn H; Kim D; Lee S; Suh S; Seong JK; Jeong HG; Han CE PLoS One; 2019; 14(8):e0220739. PubMed ID: 31369629 [TBL] [Abstract][Full Text] [Related]
5. The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease. Prestia A; Baglieri A; Pievani M; Bonetti M; Rasser PE; Thompson PM; Marino S; Bramanti P; Frisoni GB Suppl Clin Neurophysiol; 2013; 62():67-80. PubMed ID: 24053032 [TBL] [Abstract][Full Text] [Related]
6. Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer's disease. Sun N; Mormino EC; Chen J; Sabuncu MR; Yeo BTT; Neuroimage; 2019 Nov; 201():116043. PubMed ID: 31344486 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets. Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL; Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169 [TBL] [Abstract][Full Text] [Related]
8. Spatial Patterns of Longitudinal Gray Matter Change as Predictors of Concurrent Cognitive Decline in Amyloid Positive Healthy Subjects. Araque Caballero MÁ; Klöppel S; Dichgans M; Ewers M; J Alzheimers Dis; 2017; 55(1):343-358. PubMed ID: 27662291 [TBL] [Abstract][Full Text] [Related]
9. Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study. Ramos Bernardes da Silva Filho S; Oliveira Barbosa JH; Rondinoni C; Dos Santos AC; Garrido Salmon CE; da Costa Lima NK; Ferriolli E; Moriguti JC Neuroimage Clin; 2017; 15():15-24. PubMed ID: 28459000 [TBL] [Abstract][Full Text] [Related]
10. Discerning mild cognitive impairment and Alzheimer Disease from normal aging: morphologic characterization based on univariate and multivariate models. Liao W; Long X; Jiang C; Diao Y; Liu X; Zheng H; Zhang L; Acad Radiol; 2014 May; 21(5):597-604. PubMed ID: 24433704 [TBL] [Abstract][Full Text] [Related]
11. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease. Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108 [TBL] [Abstract][Full Text] [Related]